Literature DB >> 12410020

Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?

Farzana Kapadia1, David Vlahov, Don C Des Jarlais, Steffanie A Strathdee, Lawrence Ouellet, Peter Kerndt, Edward V Morse E, Ian Williams, Richard S Garfein.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) has emerged as a major public health problem among injection drug users. In this analysis we examine whether disinfection of syringes with bleach has a potentially protective effect on anti-HCV seroconversion.
METHODS: We conducted a nested case-control study comparing 78 anti-HCV seroconverters with 390 persistently anti-HCV seronegative injection drug users. These data come from the Second Collaborative Injection Drug Users Study, a prospective cohort study that recruited injection drug users from five U.S. cities between 1997 and 1999. We used conditional logistic regression to determine the effect of bleach disinfection of syringes on anti-HCV seroconversion.
RESULTS: Participants who reported using bleach all the time had an odds ratio (OR) for anti-HCV seroconversion of 0.35 (95% confidence interval = 0.08-1.62), whereas those reporting bleach use only some of the time had an odds ratio of 0.76 (0.21-2.70), when compared with those reporting no bleach use.
CONCLUSIONS: These results suggest that bleach disinfection of syringes, although not a substitute for use of sterile needles or cessation of injection, may help to prevent HCV infection among injection drug users.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410020     DOI: 10.1097/00001648-200211000-00023

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  19 in total

Review 1.  Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.

Authors:  Enrique R Pouget; Holly Hagan; Don C Des Jarlais
Journal:  Addiction       Date:  2012-04-17       Impact factor: 6.526

2.  HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women.

Authors:  Samuel R Friedman; Danielle C Ompad; Carey Maslow; Rebecca Young; Patricia Case; Sharon M Hudson; Theresa Diaz; Edward Morse; Susan Bailey; Don C Des Jarlais; Theresa Perlis; Amber Hollibaugh; Richard S Garfein
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

3.  Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior.

Authors:  Holly Hagan; Jennifer V Campbell; Hanne Thiede; Steffanie A Strathdee; Lawrence Ouellet; Mary Latka; Sharon Hudson; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2007-03-23       Impact factor: 4.492

4.  A time since onset of injection model for hepatitis C spread amongst injecting drug users.

Authors:  S Corson; D Greenhalgh; S J Hutchinson
Journal:  J Math Biol       Date:  2012-08-28       Impact factor: 2.259

5.  Childhood sexual abuse and age at initiation of injection drug use.

Authors:  Danielle C Ompad; Robin M Ikeda; Nina Shah; Crystal M Fuller; Susan Bailey; Edward Morse; Peter Kerndt; Carey Maslow; Yingfeng Wu; David Vlahov; Richard Garfein; Steffanie A Strathdee
Journal:  Am J Public Health       Date:  2005-04       Impact factor: 9.308

Review 6.  A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 7.  Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Authors:  Lisa Maher; Bethany White; Margaret Hellard; Annie Madden; Maria Prins; Thomas Kerr; Kimberly Page
Journal:  Vaccine       Date:  2010-09-09       Impact factor: 3.641

8.  Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.

Authors:  P De; E Roy; J-F Boivin; J Cox; C Morissette
Journal:  J Viral Hepat       Date:  2008-01-20       Impact factor: 3.728

9.  The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus; Mary M Mitchell; Eszter Ujhelyi
Journal:  Drug Alcohol Depend       Date:  2008-12-05       Impact factor: 4.492

10.  The cost-effectiveness of Vancouver's supervised injection facility.

Authors:  Ahmed M Bayoumi; Gregory S Zaric
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.